- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05896852
Healthy Lifestyles: A Home Based Physical Activity Intervention in Persons Living With HIV
June 6, 2023 updated by: Georgetown University
This study is being done to understand how a physical activity walking intervention affects metabolic parameters (i.e., blood sugar, cholesterol, certain body measurements) in people with and without HIV.
This study involves a physical activity intervention where participants will progressively increase activity as tolerated over a six month period.
Study Overview
Status
Not yet recruiting
Conditions
Intervention / Treatment
Detailed Description
This study is being done to understand how a physical activity walking intervention affects metabolic parameters (i.e., blood sugar, cholesterol, certain body measurements) in people with and without HIV.
This study involves a physical activity intervention where participants will progressively increase the total number of daily steps to approximately 10,000 steps/day as tolerated.
We will monitor participant steps and physical activity using a physical activity monitor.
The study will consist of 5 in-person study visits where participants will complete body measurements, laboratory testing (for metabolic parameters e.g.
blood sugar and cholesterol), and a questionnaire.
Study Type
Interventional
Enrollment (Estimated)
50
Phase
- Not Applicable
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Yes
Description
Inclusion Criteria:
- Age ≥ 18
- Persons living with or without HIV
- Metabolic Syndrome or risk factors for metabolic syndrome with BMI >=30
- Able to provide informed consent
- No physical limitations that prevent walking for more than 10 minutes
- Can provide evidence of medical clearance by healthcare provider, if required before or during the study
Exclusion Criteria:
- Currently exercising regularly (at least 2x weekly of at least 20minutes of moderate or vigorous activity)
- Current enrollment in another physician activity and/or dietary clinical trial or on diet/weight-loss program
- Active plans for bariatric surgery
- Inability to commit to the intervention schedule
- Not eligible as per screening form
- Currently pregnant or planning to become pregnant
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Intervention Arm
Participants will increase their physical activity over 6 months as tolerated,
|
Participants will increase their physical activity through walking.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Acceptability of Study Activities (Recruitment)
Time Frame: 6 months
|
To determine acceptability of study activities investigators will determine overall recruitment and determine percentage of the target recruitment that enrolled in the study at the 6 month study completion point (goal = 90% of our target).
|
6 months
|
Acceptability of Study Activities (Attrition)
Time Frame: 6 months
|
Investigators will measure attrition by determination of the number of participants who complete all study visits (measured by total number of participants who complete the baseline, 3-month, and 6-month study visits - goal >75%).
These will be assessed at the end of the 6-month study period.
|
6 months
|
Adherence to Study Activities of Study Activities
Time Frame: 6 months
|
Investigators will determine adherence to study activities by determination of the completion of study visits, completion of laboratory testing at study visits, and completion of step counting journals.
Investigators will assess total number of documented study visits, completion of laboratory testing, and assessment of total number of days steps were entered in step logs.
Investigators will assess the total number of visits, laboratory blood draws, and entries in to step log at each visit and determine overall percentage completed.
|
6 months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Metabolic Parameters (Laboratory Measurement - blood glucose)
Time Frame: 6 months
|
Laboratory measurements including fasting blood glucose (mg/dL) will be at baseline, 3-month, and 6-month visits.
Change (increase/decrease) in the fasting blood glucose measurement will be assessed.
|
6 months
|
Metabolic Parameters (Laboratory Measurement - lipids)
Time Frame: 6 months
|
Laboratory measurements including lipids (mg/dL) will be at baseline, 3-month, and 6-month visits.
Change (increase/decrease) in the lipid measurements will be assessed.
|
6 months
|
Metabolic Parameters (Laboratory Measurement - HBA1c)
Time Frame: 6 months
|
Laboratory measurements including HBA1c (mmol/mol) will be measured at baseline, 3-month, and 6-month visits.
Change (increase/decrease) in the HBA1c measurement will be assessed.
|
6 months
|
Body Composition (Waist Circumference [cm])
Time Frame: 6 months
|
Body measurement including waist circumference in centimeters will be assessed at baseline, 3-month, and 6-month follow-up visits.
Changes (increase/decrease) waist circumference will be assessed.
|
6 months
|
Body Composition (BMI [kg/m^2])
Time Frame: 6 months
|
Body measurement including BMI [kg/m^2] will be assessed at baseline, 3-month, and 6-month follow-up visits.
Changes (increase/decrease) BMI will be assessed.
|
6 months
|
Quality of Life (Health-Related Quality of Life (SF-36))
Time Frame: 6 months
|
Health related quality of life will be assessed using the Health-Related Quality of Life (SF-36) scale.
The scale includes eight measures - physical functioning, role physical, bodily pain, general health, vitality, social functioning, role emotional, and mental health.
Scores range from 0 (worst) to 100 (best).
Changes will be assessed from baseline to responses at the 6 month follow-up.
|
6 months
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Estimated)
June 1, 2023
Primary Completion (Estimated)
July 1, 2024
Study Completion (Estimated)
October 1, 2025
Study Registration Dates
First Submitted
May 11, 2023
First Submitted That Met QC Criteria
June 6, 2023
First Posted (Actual)
June 9, 2023
Study Record Updates
Last Update Posted (Actual)
June 9, 2023
Last Update Submitted That Met QC Criteria
June 6, 2023
Last Verified
May 1, 2023
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- STUDY00004962
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Metabolic Syndrome
-
Universidad de los Andes, ChileCompleted
-
Taipei Medical University WanFang HospitalUnknownMetabolic Cardiovascular SyndromeTaiwan
-
Mayo ClinicCompleted
-
SanofiBristol-Myers SquibbCompletedMetabolic Syndrome xUnited States
-
University of HohenheimGerman Federal Ministry of Education and ResearchCompleted
-
The Catholic University of KoreaCompletedMetabolic Syndrome X | Metabolic Cardiovascular Syndrome | Insulin Resistance Syndrome X | Dysmetabolic Syndrome XKorea, Republic of
-
Charite University, Berlin, GermanyRecruitingMetabolic Syndrome, Protection AgainstGermany
-
Wageningen University and ResearchPhilips Healthcare; TNO; Friesland Campina; Albert Heijn; Menzis; Smart with food; Vi... and other collaboratorsCompletedMetabolic Syndrome, Protection AgainstNetherlands
-
Cairo UniversityCompletedMetabolic Syndrome in WomenEgypt
-
Andalas UniversityHasanuddin University; Universitas Sumatera UtaraCompletedMetabolic Syndrome, Protection AgainstIndonesia
Clinical Trials on physical activity
-
Health Education Research Foundation (HERF)CompletedQuality of LifePakistan
-
Zohra Institute of Health SciencesCompletedPhysical Activity and StressPakistan
-
Centre Hospitalier Universitaire DijonWithdrawn
-
AUSL Romagna RiminiFondazione IRCCS Istituto Nazionale dei Tumori, MilanoRecruitingNon-Small Cell Lung CancerItaly
-
Fundación para la Investigación del Hospital Clínico...CompletedObesity | Severe Mental Disorder
-
Augusta UniversityNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); Kansas... and other collaboratorsCompletedMental Disorders, SevereUnited States
-
Centre Hospitalier Departemental VendeeTerminated
-
Rio de Janeiro State UniversityCompleted
-
Cardenal Herrera UniversityRecruiting
-
Istituti Clinici Scientifici Maugeri SpAActive, not recruiting